CBaBC SRL
The score of CBaBC shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +158 % Total assets +84 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CBaBC's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Apr 2026
- Year ended 31 Dec 2024filed on 07 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
CBaBC's financial analysis
- Solvency91.3%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CBaBC
CBaBC's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0783.308.058
- VAT number
- BE0783308058
- Peppol
- Registered · 0208:0783308058 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Mar 2022
- Registered office
- 9070 Destelbergen
- Latest accounts
- 2025 · filed on 28 Apr 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
CBaBC (SRL) has been based in Destelbergen since 2022, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 85,609 € and equity of 227,814 €; its revenue is not published. Its solvency stands at 91.3%, above the median of its sector (60.4%).
Companies similar to CBaBC
Companies in the same business, of comparable size and area, outside its group.
- Thomas De Beer Consulting Research and experimental development on natural sciences and engineering Deinze · balance sheet 252,275 €
- ProteoFormiX Research and experimental development on natural sciences and engineering Vorselaar · balance sheet 182,817 €
- Perpetuum CropScience Research and experimental development on natural sciences and engineering Beveren-Kruibeke-Zwijndrecht · balance sheet 181,346 €
- EDF Quality Services Research and experimental development on natural sciences and engineering Zoersel · balance sheet 313,863 €
- NuStats Lab Research and experimental development on natural sciences and engineering Erpe-Mere · balance sheet 118,033 €
- Opero Research and experimental development on natural sciences and engineering Grimbergen · balance sheet 225,981 €
- Thalen Biotech Consultancy Research and experimental development on natural sciences and engineering Frasnes-lez-Anvaing · balance sheet 215,550 €
- Bio-Perspectives Research and experimental development on natural sciences and engineering Ixelles · balance sheet 206,760 €
Frequently asked questions about CBaBC
What is the revenue of CBaBC?
CBaBC files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of CBaBC?
In Belgium, the VAT number is the company number prefixed with BE: BE0783308058 for CBaBC, if the company is VAT-registered. Its company number (CBE) is 0783.308.058.
Where is the registered office of CBaBC?
According to the CBE register, the registered office of CBaBC is in 9070 Destelbergen.
What is the equity of CBaBC?
At the close of the 2025 financial year, the equity of CBaBC amounts to 227,814 €, a solvency of 91.3% of total assets.
Who manages CBaBC?
The register lists 1 active mandates at CBaBC. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CBaBC
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →